{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:12:11Z","timestamp":1761988331000,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.cbi.2010.10.006","type":"journal-article","created":{"date-parts":[[2010,10,22]],"date-time":"2010-10-22T04:24:20Z","timestamp":1287721460000},"page":"136-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Potential implication of aniline derivatives in the Toxic Oil Syndrome (TOS)"],"prefix":"10.1016","volume":"192","author":[{"given":"Angel","family":"Messeguer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2010.10.006_bib0005","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(81)90949-1","article-title":"Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline","volume":"2","author":"Tabuenca","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2010.10.006_bib0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0378-4274(92)90173-H","article-title":"The Toxic Oil Syndrome (TOS 1981): from the disease towards a toxicological understanding of its chemical etiology and mechanism","volume":"64\u201365","author":"Aldridge","year":"1992","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2010.10.006_bib0015","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0140-6736(83)91005-X","article-title":"New aniline derivatives in cooking oils associated with toxic oil s\u00edndrome","volume":"2","author":"V\u00e1zquez Roncero","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2010.10.006_bib0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/oxfordjournals.epirev.a000804","article-title":"Toxic Oil Syndrome: the perspective after twenty years","volume":"23","author":"Posada de la Paz","year":"2001","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.cbi.2010.10.006_bib0025","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1021\/tx990105j","article-title":"Biotransformation and clearance of 3-(phenylamino)propane-1,2-diol, a compound present in samples related to Toxic Oil Syndrome, in C57BL\/6 and A\/J mice","volume":"12","author":"Ladona","year":"1999","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2010.10.006_bib0030","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1021\/tx010001k","article-title":"Metabolism of (R)- and (S)-3(phenylamino)propane-1,2-diol in C57BL\/6- and A\/J-strain mice. Identification of new metabolites with toxicological significance to the Toxic Oil Syndrome","volume":"14","author":"Bujons","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2010.10.006_bib0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00217625","article-title":"Possible etiologic agents for Toxic Oil Syndrome: fatty acid esters of 3-(N-phenylamino)-1,2-propanediol","volume":"28","author":"Hill","year":"1995","journal-title":"Arch. Environ. Contam. Toxicol."},{"key":"10.1016\/j.cbi.2010.10.006_bib0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0278-6915(00)00111-3","article-title":"Storage time and deodorisation temperature influence the formation of aniline-derived compounds in denatured rapeseed oils","volume":"39","author":"Ruiz-M\u00e9ndez","year":"2001","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.cbi.2010.10.006_bib0045","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1021\/tx0497595","article-title":"On the formation and chemical interconversion of 3-N-Phenylamino-1,2-propanediol derivatives in a Toxic Oil Syndrome model oil","volume":"18","author":"Morat\u00f3","year":"2005","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2010.10.006_bib0050","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/jms.1185","article-title":"Characterization of new aniline derivatives of fatty acids and triglycerides in samples of laboratory refined rapeseed oil denatured with aniline","volume":"42","author":"Reig","year":"2007","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.cbi.2010.10.006_bib0055","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.tet.2008.09.102","article-title":"Studies on the Toxic Oil Syndrome: proposal of a mechanism for the thermal conversion of 3-N-phenylamino-1,2-propanediol esters into anilides under deodorisation conditions","volume":"65","author":"Escabr\u00f3s","year":"2009","journal-title":"Tetrahedron"},{"key":"10.1016\/j.cbi.2010.10.006_bib0060","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/tx049952z","article-title":"Studies on Toxic Oil Syndrome: stereoselective hydrolysis of 3-(phenylamino)propane-1,2-diol esters by human pancreatic lipase","volume":"17","author":"Morat\u00f3","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2010.10.006_bib0065","series-title":"Toxic Oil Syndrome: Current Knowledge and Future Perspectives, WHO Reg. Eur. Ser. No 42","first-page":"26","article-title":"Clinical findings","author":"Abaitua-Borda","year":"1992"},{"key":"10.1016\/j.cbi.2010.10.006_bib0070","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1021\/tx700209p","article-title":"In vitro bioactivation of 3-N-Phenylamino-1,2-propanediol by human and rat liver microsomes and recombinant P450 isoforms. Implications for Toxic Oil Syndrome","volume":"20","author":"Mart\u00ednez-Cabot","year":"2007","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2010.10.006_bib0075","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0940-2993(99)80031-1","article-title":"Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue","volume":"51","author":"Raunio","year":"1999","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.cbi.2010.10.006_bib0080","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/20024091064273","article-title":"Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung","volume":"32","author":"Hukkanen","year":"2002","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.cbi.2010.10.006_bib0085","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.etp.2005.05.008","article-title":"Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach","volume":"57","author":"Castell","year":"2005","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.cbi.2010.10.006_bib0090","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ijc.10937","article-title":"CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer","volume":"104","author":"Silvestri","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cbi.2010.10.006_bib0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2133\/dmpk.17.167","article-title":"Genetic polymorphism","volume":"17","author":"Nagata","year":"2002","journal-title":"Drug Metabol. Pharmacokin."},{"key":"10.1016\/j.cbi.2010.10.006_bib0100","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1021\/tx050171n","article-title":"Synthesis and stability studies of the glutathione and N-acetylcysteine adducts of an quinoneimine reactive intermediate generated in the biotransformation of 3-(N-phenylamino)propane-1,2-diol: implications for toxic oil syndrome","volume":"18","author":"Mart\u00ednez-Cabot","year":"2005","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2010.10.006_bib0105","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1021\/ja050974x","article-title":"Site-specific binding of quinone to proteins through thiol addition and addition-elimination reactions","volume":"127","author":"Li","year":"2005","journal-title":"J. Am. Chem Soc."},{"key":"10.1016\/j.cbi.2010.10.006_bib0110","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0041-008X(92)90372-Y","article-title":"p-Aminophenol nephrotoxicity: biosynthesis of toxic glutathione conjugates","volume":"115","author":"Klos","year":"1992","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2010.10.006_bib0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF03035706","article-title":"Nephrotoxicity of 4-amino-3-S-glutathionylphenol and its modulation by metabolism or transport inhibitors","volume":"68","author":"Fowler","year":"1994","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2010.10.006_bib0120","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/jid.1993.31","article-title":"l-Tryptophan and the eosinophilia-myalgia syndrome: current understanding of the etiology and pathogenesis","volume":"100","author":"Varga","year":"1993","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cbi.2010.10.006_bib0125","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1172\/JCI117125","article-title":"A murine model of the eosinophilia-myalgia syndrome induced by 1,1\u2032-ethylidenebis (l-tryptophan)","volume":"93","author":"Silver","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cbi.2010.10.006_bib0130","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/tx00049a003","article-title":"Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome","volume":"8","author":"Mayeno","year":"1995","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2010.10.006_bib0135","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1021\/tx700256v","article-title":"Generation of quinoneimine Intermediates in the Bioactivation of 3-(N-Phenylamino)alanine (PAA) by Human Liver Microsomes. A potential link between the Eosinophilia-Myalgia Syndrome and the Toxic Oil Syndrome","volume":"20","author":"Mart\u00ednez-Cabot","year":"2007","journal-title":"Chem. Res. Toxicol."},{"year":"2004","series-title":"Toxic Oil Syndrome. Ten Years of Progress","key":"10.1016\/j.cbi.2010.10.006_bib0140"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279710005855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279710005855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:25:58Z","timestamp":1757856358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279710005855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":28,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0009279710005855"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2010.10.006","relation":{},"ISSN":["0009-2797"],"issn-type":[{"type":"print","value":"0009-2797"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential implication of aniline derivatives in the Toxic Oil Syndrome (TOS)","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2010.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}